Most recently, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to the wide array of endogenous opioids. Contrary to most opioid receptors, this receptor functions as being a scavenger and doesn't activate a 2nd me